Production (Stage)
PDS Biotechnology Corporation
PDSB
$1.69
$0.138.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.94% | 27.03% | 1.13% | 27.80% | -9.77% |
| Total Depreciation and Amortization | 4.86% | 4.86% | 4.86% | 4.86% | 2.13% |
| Total Amortization of Deferred Charges | 0.89% | 14.49% | 92.61% | 154.53% | 121.48% |
| Total Other Non-Cash Items | -10.59% | -6.89% | -15.87% | -25.69% | -23.85% |
| Change in Net Operating Assets | -83.16% | -658.82% | -54.68% | -175.72% | 78.48% |
| Cash from Operations | 9.12% | 2.63% | -11.48% | -83.99% | 24.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23,157.78% | -23,683.33% | -9.30% | -9.52% | 34.78% |
| Issuance of Common Stock | -63.54% | -69.27% | -96.16% | -100.00% | 336.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.42% | -98.39% | -97.86% | -105.75% | 338.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.98% | -449.13% | -25.24% | -94.58% | 216.86% |